Goldman Sachs Group »

Aldeyra Therapeutics shares owned by Goldman Sachs Group

Quarter-by-quarter ownership of Aldeyra Therapeutics (ALDX) shares owned by Goldman Sachs Group from 13F filings

Historical chart of Goldman Sachs Group investment in Aldeyra Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aldeyra Therapeutics held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aldeyra Therapeutics by Goldman Sachs Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $518k 148k 3.51
2023-09-30 $1.1M 169k 6.68
2023-06-30 $1.7M 197k 8.39
2023-03-31 $2.9M 287k 9.93
2022-12-31 $165k 24k 6.96
2022-06-30 $4.7M 1.2M 3.99
2022-03-31 $6.2M 1.4M 4.44
2021-12-31 $410k 103k 3.99
2021-09-30 $1.1M 122k 8.78
2021-03-31 $899k 76k 11.89
2020-12-31 $295k 43k 6.87
2020-09-30 $219k 30k 7.41
2020-06-30 $155k 37k 4.18
2019-12-31 $576k 99k 5.81
2019-09-30 $423k 80k 5.27
2019-06-30 $97k 16k 5.97
2019-03-31 $112k 12k 9.05
2018-12-31 $154k 19k 8.31
2018-09-30 $378k 27k 13.78
2018-03-31 $117k 16k 7.52